Based on the involvement of EP300/CREBBP in multiple pathways associated with castration resistance, we hypothesized that targeting the HAT or BD domains of EP300 and CREBBP may regulate cellular processes in enzalutamide-resistant PCa cells. Here, EP300 is linked to posterior cortical atrophy.